| Product Name | MF | CAS | Details |
|---|
| SW2_110A | C42H60N6O7 | 2579696-95-8 | Details |
| Bax inhibitor peptide V5 acetate, 10 mM in DMSO | Details |
| SZL P1-41, 10 mM in DMSO | C24H24N2O3S | 222716-34-9 | Details |
| T0901317, 10 mM in DMSO | C17H12F9NO3S | 293754-55-9 | Details |
| CPI-0610 carboxylic acid | C20H15ClN2O3 | 1380089-81-5 | Details |
| VH032-cyclopropane-F, 10 mM in DMSO | C26H33FN4O5S | 2306193-99-5 | Details |
| Azepexole hydrochloride, 10 mM in DMSO | C9H16ClN3O | 147663-20-5 | Details |
| NPS ALX Compound 4a hydrochloride(1:1) | Details |
| 1-Myristoyl-2-stearoyl-sn-glycero-3-phosphocholine | C40H80NO8P | 76343-22-1 | Details |
| PKA inhibitor fragment (6-22) amide Acetate, 10 mM in DMSO | Details |
| Desformylflustrabromine hydrochloride | C16H22BrClN2 | 951322-11-5 | Details |
| SYP-5, 10 mM in DMSO | C18H16O3S | 1384268-04-5 | Details |
| SYM2206, 10 mM in DMSO | C20H22N4O3 | 173952-44-8 | Details |
| SW106065, 10 mM in DMSO | C10H8N2OS | 62289-81-0 | Details |
| Vipivotide tetraxetan | C49H71N9O16 | 1702967-37-0 | Details |
| SMARCA-BD ligand 1 for Protac dihydrochloride | C14H18ClN5O | 2369053-68-7 | Details |
| Thalidomide-O-amido-PEG-C2-NH2 hydrochloride, 10 mM in DMSO | C19H23ClN4O7 | 2204226-02-6 | Details |
| Cytochrome c - pigeon (88-104) Acetate | Details |
| Acetyl Angiotensinogen (1-14), porcine Acetate | Details |
| Ac-Endothelin-1 (16-21), human acetate | Details |
| Dimebolin, 10 mM in DMSO | C21H25N3 | 3613-73-8 | Details |
| β-Interleukin I (163-171), human Acetate, 10 mM in DMSO | Details |
| Epidermal Growth Factor Receptor Peptide Acetate, 10 mM in DMSO | Details |
| (Rac)-5-Keto Fluvastatin | C24H24FNO4 | 1160169-39-0 | Details |
| Dabigatran ethyl ester hydrochloride, 10 mM in DMSO | C27H30ClN7O3 | 211914-50-0 | Details |
| 4-Azido-L-phenylalanine hydrochloride, 10 mM in DMSO | C9H11ClN4O2 | 34670-43-4 | Details |
| N-(2-Chloro-6-methylphenyl)-N''-4-pyridinylurea, 10 mM in DMSO | C13H12ClN3O | 97627-24-2 | Details |
| T025, 10 mM in DMSO | C21H18N8 | 2407433-00-3 | Details |
| SYM 2081 | C6H11NO4 | 31137-74-3 | Details |
| SX-682, 10 mM in DMSO | C19H14BF4N3O4S | 1648843-04-2 | Details |
| AZ-Dyrk1B-33, 10 mM in DMSO | C19H16N4 | 1679330-37-0 | Details |
| Beta-Lipotropin (1-10), porcine Acetate | Details |
| Mal-PEG1-Val-Cit-OH | Details |
| NPS ALX Compound 4a hydrochloride(1:1), 10 mM in DMSO | Details |
| 1-Oleoyl lysophosphatidic acid sodium | C21H40NaO7P | 325465-93-8 | Details |
| FBPase-1 inhibitor-1, 10 mM in DMSO | C13H7Cl3N2O3S | 883973-99-7 | Details |
| T16Ainh-A01 | C19H20N4O3S2 | 552309-42-9 | Details |
| T-00127_HEV1, 10 mM in DMSO | C22H29N5O3 | 900874-91-1 | Details |
| Syk Inhibitor II dihydrochloride, 10 mM in DMSO | C14H16ClF3N6O | 227449-73-2 | Details |
| (4R)-RO5263397 | C10H11FN2O | 1357266-80-8 | Details |
| (2R,3S)-Azelaprag | 2049979-31-7 | Details |
| AZ 11645373, 10 mM in DMSO | C24H21N3O5S | 227088-94-0 | Details |
| SW155246, 10 mM in DMSO | C16H11ClN2O5S | 420092-79-1 | Details |
| SXC 2023 | C13H15NO4S | 1695562-36-7 | Details |
| T-1101 tosylate, 10 mM in DMSO | C31H31N5O6S3 | 2250404-95-4 | Details |
| T0070907, 10 mM in DMSO | C12H8ClN3O3 | 313516-66-4 | Details |
| PKA inhibitor fragment (6-22) amide Acetate | Details |
| Bax inhibitor peptide V5 acetate | Details |
| Beta-Sheet Breaker Peptide iAβ5 Acetate, 10 mM in DMSO | Details |
| Beta-Lipotropin (1-10), porcine Acetate, 10 mM in DMSO | Details |
| Propargyl-PEG17-methane | C36H70O17 | 2169967-47-7 | Details |
| (S,R,S)-AHPC-PEG3-NH2 hydrochloride | C30H46ClN5O7S | 2097971-11-2 | Details |
| Cl-C6-PEG4-O-CH2COOH | C16H31ClO7 | 1799506-30-1 | Details |
| Thalidomide-O-amido-C6-NH2 hydrochloride | C21H27ClN4O6 | 2376990-31-5 | Details |
| β-Interleukin I (163-171), human Acetate | Details |
| Systemin acetate(137181-56-7 free base) | Details |
| eukaryotic translation elongation factor 1 alpha 1 (EEF1A1) (387-394) [Multiple species]（TFA) | Details |
| Dihydroxyacetone phosphate hemimagnesium salt hydrate | Details |
| Acetyl Angiotensinogen (1-14), porcine Acetate, 10 mM in DMSO | Details |
| GnRH Associated Peptide (GAP) (1-13), human Acetate | C65H101N15O25 | 100111-07-7 | Details |
| 1-(1-Naphthyl) piperazine hydrochloride, 10 mM in DMSO | C14H17ClN2 | 104113-71-5 | Details |
| SB399885, 10 mM in DMSO | C18H21Cl2N3O4S | 402713-80-8 | Details |
| SW033291, 10 mM in DMSO | C21H20N2OS3 | 459147-39-8 | Details |
| N-Desethyl Chloroquine Hydrochloride | C16H23Cl2N3 | 15912-96-6 | Details |
| T-0509 | C18H23NO5 | 96843-99-1 | Details |
| Syk Inhibitor II hydrochloride, 10 mM in DMSO | C14H16ClF3N6O | 2490508-82-0 | Details |
| Dynamin inhibitory peptide Acetate | Details |
| Aspartyl-alanyl-diketopiperazine acetate, 10 mM in DMSO | Details |
| NOT Receptor Modulator 1, 10 mM in DMSO | C22H19ClN2O | 1015231-98-7 | Details |
| (S,R,S)-AHPC-PEG4-NH2 | C32H49N5O8S | 2010159-57-4 | Details |
| SYR127063, 10 mM in DMSO | C23H20ClF3N4O3 | 871026-18-5 | Details |
| SW-100, 10 mM in DMSO | C17H17ClN2O2 | 2126744-35-0 | Details |
| Carcinine ditrifluoroacetate Acetate | C8H14N4O | 56897-53-1 | Details |
| T-0156 | C31H29N5O7 | 324572-92-1 | Details |
| SynuClean-D, 10 mM in DMSO | C13H5F3N4O5 | 685121-45-3 | Details |
| T-2000 | C20H20N2O5 | 97846-21-4 | Details |
| UK 227786, 10 mM in DMSO | C22H21ClN4O4.ClH | 150452-21-4 | Details |
| Beta-Sheet Breaker Peptide iAβ5 Acetate | Details |
| GnRH Associated Peptide (GAP) (1-13), human Acetate, 10 mM in DMSO | Details |
| Dynamin inhibitory peptide Acetate, 10 mM in DMSO | Details |
| 2,3-dihydrothieno-Thiadiazole Carboxylate | C6H4N2O2S2 | 152467-47-5 | Details |
| SW044248, 10 mM in DMSO | C22H23N5O2S | 522650-83-5 | Details |
| Syk Inhibitor II, 10 mM in DMSO | C14H15F3N6O | 726695-51-8 | Details |
| Synta66, 10 mM in DMSO | C20H17FN2O3 | 835904-51-3 | Details |
| 2,3,4,6-Tetra-o-acetyl-alpha-galactosylpyranosyl bromide | C14H19BrO9 | 529493-92-3 | Details |
| (S,R,S)-AHPC-PEG4-N3 | C32H47N7O8S | 1797406-81-5 | Details |
| Thalidomide-O-amido-C6-NH2 TFA, 10 mM in DMSO | C23H27F3N4O8 | 1950635-14-9 | Details |
| DMAB-anabaseine dihydrochloride | C19H22ClN3 | 154149-38-9 | Details |
| diABZI STING agonist-1 (Tautomerism) | C42H51N13O7 | 2138498-18-5 | Details |
| Omeprazole metabolite Omeprazole sulfone | C17H19N3O4S | 88546-55-8 | Details |
| I-OMe-Tyrphostin AG 538, 10 mM in DMSO | C17H12INO5 | 1094048-77-7 | Details |
| SY-640 | C11H13NO3 | 168705-70-2 | Details |
| Epidermal Growth Factor Receptor Peptide Acetate | Details |
| Anti-Inflammatory Peptide 1 Acetate | Details |
| Syntide 2 acetate(108334-68-5 free base) | Details |
| Methyl 3-[2-[[(4R)-4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl]methylamino]ethyl]benzoate | C27H36N2O4 | 2725484-87-5 | Details |
| Anti-Inflammatory Peptide 1 Acetate, 10 mM in DMSO | Details |
| Cytochrome c - pigeon (88-104) Acetate, 10 mM in DMSO | Details |
| T-1095, 10 mM in DMSO | C26H28O11 | 209746-59-8 | Details |
| SY-5609, 10 mM in DMSO | C23H26F3N6OP | 2417302-07-7 | Details |
| Product Total： Product Page： | ||||
| 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 | ||||